Recurrent Respiratory Tract Infection of Chinese medicine in prevention and treatment.docVIP

 PAGE \* MERGEFORMAT 46 Recurrent Respiratory Tract Infection of Chinese medicine in prevention and treatment Abstract Recurrent respiratory infections in children 1 year refers to the upper and lower respiratory tract infection as a recurrent clinical syndrome, is a pediatric clinical, one of the most common diseases. More common in infants under the age of 6, in the winter and spring easy to attack. Clinical to repeated colds, chronic cough unhealed, spontaneous perspiration, characterized by an air cowardly. Emphasis on disease symptoms, course and long, lingering refractory seriously affect children’s health and growth and development. Chinese medicine in the prevention and treatment of the disease has a distinct advantage, particularly in reducing the recurrence rate and improve the efficacy of outstanding aspects of immune function. This comprehensive analysis of the past five years, Chinese medicine Recurrent Respiratory Tract Infection prevention and control literature, with emphasis on traditional Chinese medicine theory, awareness of the disease, Chinese medicine treatment of sub-type, non-pharmacological treatment, as well as traditional Chinese medicine the prevention and care. Keywords: Recurrent Respiratory Tract Infection of Chinese Medicine Overview Recurrent Respiratory Tract Infection (Recurrent Respiratory Tract Infections, RRTI), referred to as “re-sense of children” refers to the unit of time, the lower respiratory tract infections exceeds the number of repeated episodes of a clinical syndrome [1]. Particularly prevalent in the age of onset from 6 months to 6 years old children, 1 to 3 years the most common in infants; onset time for winter and spring-prone, and has repeatedly incessantly, some children in the summer there is a natural tendency to ease; clinical characteristics of a perennial attack, the symptoms heavier, the course is longer, lingering refractory seriously affect children’s health and growth and dev